SEGOVA
LIVE

Serial Number

79308367

Owner

Vincula Biotech Group d.o.o.

Attorney

Alexander Lazouski

Filing Date

Nov 12, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SEGOVA Trademark

Serial Number: 79308367 • Registration: 6648925

SEGOVA is a trademark filed by Vincula Biotech Group d.o.o. on November 12, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Vincula Biotech Group d.o.o.

Skenderbegova 3

Entity Type: 99

Forever Young d.o.o.

Skenderbegova 3

Entity Type: 99

Trademark Details

Filing Date

November 12, 2020

Registration Date

February 22, 2022

Published for Opposition

December 7, 2021

Goods & Services

Alcohols for pharmaceutical use; alcohol for topical application; analgesics; anesthetics; antibacterial products for washing hands, namely, antibacterial handwash; antibacterial cleaners; antibacterial preparations, namely, antibacterial cleaners; antiseptic preparations; balms for veterinary use; biological preparations for medical use for the treatment of reproductive health diseases, disorders and conditions; biological reagents for medical use; biotechnological preparations for medical use for the treatment of reproductive health diseases, disorders and conditions; multi-purpose medicated antibiotic creams; lint for medical use; disinfectants; diagnostic substances, preparations and agents for medical use; medical dressings; contrast products used with medical equipment, namely, contrast media for in-vivo imaging for medical use; blood for medical use; medicinal and pharmaceutical preparations used for the treatment of reproductive health diseases, disorders and conditions; drugs for medical use, namely, pharmaceutical preparations for the treatment of reproductive health diseases, disorders and conditions; stem cells for medical use; surgical implants grown from stem cells; surgical implants made of living tissue; biological tissue cultures for medical use; hygiene preparations for medical use, namely, disinfectants; dietetic beverages and foods for medical use; food supplements for human beings; reagents for use in medical genetic testing; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical substances and preparations used in gynecology

Medical services; medical and health care services; obstetric and gynecology services; ambulatory health care services; hospital services; genetic consultation, namely, genetic counseling; genetic testing for medical use; dermatology services; DNA screening for medical use; medical services relating to the removal, treatment and transformation of stem cells; medical services relating to the collection, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow; health and beauty care for human beings; medical equipment rental; preparation of reports in connection with medical matters; provision of information in the field of administration of medication; medical consultancy and information services relating to medical products; medical consultant and information services relating to pharmaceutical products; medical assistance; medical care services; medical and health care clinic services; medical consultation services; medical screening; medical counselling; medical testing for diagnostic or treatment purposes; conducting of medical examinations; plastic surgery; preparation of prescriptions by pharmacists; medical information; laboratory analysis services relating to the treatment of persons, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; services provided by a doctor, namely, medical services; medical diagnosis of genetic diseases; medical clinic services; telemedicine services; medical rehabilitation clinic services; medical analysis services relating to the treatment of persons provided by a medical laboratory; pharmacy advice regarding preparation of prescriptions in pharmacies; physiotherapy

Surgical and medical apparatus and instruments for use in general surgery; genetic analysis apparatus for medical use; apparatus for the regeneration of stem cells for medical use; clinical diagnosis apparatus, namely, diagnostic apparatus for the detection of reproductive health diseases, disorders and conditions; blood testing apparatus; dropper bottles for medical use, namely, dropper bottles for administering medication, sold empty; vaginal dilators; vaginal syringes; gynecological apparatus and instruments; digital thermometers for medical use; uterine dilators; endoscopic apparatus for medical use; protective gloves for medical use; needles for medical use; injection instruments without needles; suture materials; blood collection bags for medical use; lasers for surgical use; medical instruments for cutting tissue; enema apparatus for medical use; medical apparatus for introducing pharmaceutical preparations into the human body; knives for medical use; protection devices against X-rays, for medical use, namely, patient x-ray radiation shields; pessaries; scalpels; apparatus for non-invasive surgery; ultrasound apparatus for medical use; ultrasonic diagnostic apparatus for medical use; diagnostic imaging apparatus for medical use; hygiene masks for medical use; syringes for medical use; multi-injection needle syringes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 4, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 22, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 2, 2022 FICS
FINAL DISPOSITION PROCESSED
Aug 2, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 22, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 22, 2022 R.PR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 4, 2022 ADCH
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 7, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Dec 6, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 2, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 21, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 21, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 21, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 19, 2021 GNFN
FINAL REFUSAL E-MAILED
Oct 19, 2021 GNFR
FINAL REFUSAL WRITTEN
Oct 19, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 21, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2021 TROA
REFUSAL PROCESSED BY IB
May 24, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 2, 2021 RFCS
REFUSAL PROCESSED BY MPU
May 1, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 29, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 28, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 16, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 12, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 8, 2021 REPR